Heart Failure POC & LOC Devices Market Size & Competitors

The Heart Failure POC & LOC Devices Market is evolving rapidly as health systems prioritize decentralized diagnostics and real-time data integration. Senior executives must navigate dynamic clinical practices, technology shifts, and operational factors to inform investments and strategic planning in this market segment.

Market Snapshot: Heart Failure POC & LOC Devices Market Insights

The Heart Failure POC & LOC Devices Market expanded from USD 301.92 million in 2025 to USD 348.06 million in 2026, with a projected CAGR of 13.77% leading to an expected value of USD 744.92 million by 2032. This robust trajectory reflects increasing clinical demand for early detection, scalable diagnostic solutions, and improved patient management. These market shifts underscore priorities for innovation in both hardware and software, as decision-makers look for evidence-based approaches to address chronic heart failure challenges globally.

Scope & Segmentation of the Heart Failure POC & LOC Devices Market

This report provides a comprehensive framework for understanding clinical, technical, and operational imperatives driving point-of-care and line-of-care device adoption across diverse environments:

Test Modalities: Genomic, metabolomic, and proteomic testing approaches support risk stratification, ongoing patient monitoring, and the personalization of heart failure therapy at the point of care.
Device Classes: Devices such as cardiac biomarker analyzers, imaging equipment, electrocardiogram systems, and wearables—including external defibrillators and heart rate monitors—enable intermittent to continuous monitoring tailored for various patient needs.
Technology Platforms: Solutions incorporate biosensor technologies, imaging and impedance methodologies, immunoassays, and nucleic acid-based formats to meet diverse clinical requirements and regulatory standards.
End-User Channels: Hospitals, clinics, laboratories, home care providers, and assisted living healthcare environments each introduce different workflow, connectivity, and compliance expectations, influencing device selection and adoption timelines.
Regional Coverage: Americas, Europe Middle East & Africa, and Asia-Pacific regions present varying adoption rates, local supply chain realities, and evolving regulatory frameworks that affect access and market strategies.

Key Takeaways for Senior Decision-Makers

Decentralized care models are propelling growth in portable, interoperable diagnostics, supporting earlier interventions beyond traditional clinical labs and driving enhanced patient outcomes.
Converging technologies—including biosensors, advanced imaging, and integrated digital health—are collectively enhancing clinical workflows and enabling more accurate heart failure management at the bedside and in community settings.
Regulatory changes and a heightened focus on value-based healthcare encourage manufacturers to demonstrate both clinical utility and operational usability, aligning new product development with payers’ expectations.
Supply chain resilience is now integral; organizations are strengthening regional sourcing, expanding local manufacturing capacities, and adopting modular device designs to mitigate disruptions and address rapidly shifting market demands.
Strategic collaborations between diagnostic, medtech, and digital health stakeholders are creating data-driven, multi-device ecosystems. Such partnerships are redefining competitive positioning and offering cohesive clinician support.
Successful adoption depends on seamless integration into clinical workflows, intuitive design, and the potential for measurable improvements in therapy management, patient compliance, and overall quality of life.

Tariff Impact and Commercial Response in 2025

New U.S. tariffs have introduced additional challenges in sourcing and distribution strategies for heart failure POC & LOC devices. To address cost and procurement pressures, companies are increasingly exploring nearshoring and diversified supplier models. These measures are facilitating margin protection and supporting operational continuity. Heightened attention to supplier agreements, agile partnerships, and modular upgrades is enabling greater flexibility. As organizations adjust, strategic operational alignment and value proposition clarity become more important to meet evolving procurement criteria in cost-sensitive markets.

Methodology & Data Sources

This report combines qualitative and quantitative research. Data were obtained through expert interviews, targeted literature review, and regulatory analysis. Findings are validated through input from clinicians, procurement leaders, regulatory authorities, and leading device developers to ensure robust insights and strategic guidance.

Why This Report Matters: Actionable Insights for Your Strategy

Provides senior executives with benchmarks to inform investment and operational priorities regarding decentralization, technology innovation, and supply chain adaptation.
Offers segmentation and workflow integration intelligence for optimizing go-to-market, product design, and adoption strategies across multiple end-user and regional contexts.
Supports prioritization of interoperability, clinical evidence generation, and strategic partnerships to facilitate broad adoption and sustained value creation in a competitive landscape.

Conclusion

Senior decision-makers equipped with this intelligence can align organizational strategies with evolving clinical, technological, and commercial realities in heart failure diagnostics. Integrated solutions, resilient operations, and clinical evidence will shape sustainable growth and competitive positioning across all segments.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Heart Failure POC & LOC Devices Market, by Test Type

8.1. Genomic Testing
8.2. Metabolomic Testing
8.3. Proteomic Testing

9. Heart Failure POC & LOC Devices Market, by Device Type

9.1. Diagnostic Devices
9.1.1. Cardiac Biomarker Analyzers
9.1.2. Cardiac Imaging Devices
9.1.3. Electrocardiogram (ECG)
9.2. Wearable Devices
9.2.1. External Defibrillator
9.2.2. Heart Rate Monitors

10. Heart Failure POC & LOC Devices Market, by Technology

10.1. Biosensor-based systems
10.2. Imaging & impedance-based platforms
10.3. Immunoassays
10.4. Nucleic acid-based platforms

11. Heart Failure POC & LOC Devices Market, by End User

11.1. Assisted Living Healthcare
11.2. Home Care Facilities
11.3. Hospitals & Clinics
11.4. Laboratory

12. Heart Failure POC & LOC Devices Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Heart Failure POC & LOC Devices Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Heart Failure POC & LOC Devices Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Heart Failure POC & LOC Devices Market
16. China Heart Failure POC & LOC Devices Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. ACON Laboratories Inc.
17.7. Becton, Dickinson and Company
17.8. Bio-Rad Laboratories, Inc.
17.9. bioMérieux S.A.
17.10. Boston Scientific Corporation
17.11. Cipla Limited
17.12. Danaher Corporation
17.13. F. Hoffmann-La Roche Ltd.
17.14. Fukuda Denshi Co., Ltd.
17.15. Jant Pharmacal Corporation
17.16. Johari Digital India Limited by Syrma SGS
17.17. Koninklijke Philips N.V.
17.18. LifeSign LLC
17.19. LifeSync
17.20. Luminex Corporation by DiaSorin S.p.A.
17.21. Mitsubishi Chemical Group Corporation
17.22. Nexus Dx, Inc
17.23. Nihon Kohden Corporation
17.24. Quidel Corporation
17.25. Schiller AG
17.26. Shenzhen EDAN Instrument Co., Ltd.
17.27. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17.28. Siemens Healthineers AG
17.29. Spectral Diagnostics Inc.
17.30. Trinity Biotech PLC

List of Figures

FIGURE 1. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CARDIAC BIOMARKER ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CARDIAC BIOMARKER ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CARDIAC BIOMARKER ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CARDIAC IMAGING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CARDIAC IMAGING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CARDIAC IMAGING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM (ECG), BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM (ECG), BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM (ECG), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HEART RATE MONITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HEART RATE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HEART RATE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY BIOSENSOR-BASED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY BIOSENSOR-BASED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY BIOSENSOR-BASED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY IMAGING & IMPEDANCE-BASED PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY IMAGING & IMPEDANCE-BASED PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY IMAGING & IMPEDANCE-BASED PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY NUCLEIC ACID-BASED PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY NUCLEIC ACID-BASED PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY NUCLEIC ACID-BASED PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME CARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME CARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME CARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 94. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 95. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 96. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 97. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 107. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 108. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 109. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 110. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 111. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 122. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 123. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 124. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 125. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 126. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 129. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 130. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 131. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 132. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 133. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 143. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 144. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 145. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 146. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 147. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 150. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 151. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 152. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 153. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 157. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 158. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 159. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 160. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 161. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 164. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 165. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 166. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 167. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 168. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 171. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 172. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 173. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 174. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 175. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 176. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Heart Failure POC & LOC Devices market report include:

Abbott Laboratories
ACON Laboratories Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
bioMérieux S.A.
Boston Scientific Corporation
Cipla Limited
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Fukuda Denshi Co., Ltd.
Jant Pharmacal Corporation
Johari Digital India Limited by Syrma SGS
Koninklijke Philips N.V.
LifeSign LLC
LifeSync
Luminex Corporation by DiaSorin S.p.A.
Mitsubishi Chemical Group Corporation
Nexus Dx, Inc
Nihon Kohden Corporation
Quidel Corporation
Schiller AG
Shenzhen EDAN Instrument Co., Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Siemens Healthineers AG
Spectral Diagnostics Inc.
Trinity Biotech PLC

Table Information

Report Attribute	Details
No. of Pages	191
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 348.06 Million
Forecasted Market Value ( USD ) by 2032	$ 744.92 Million
Compound Annual Growth Rate	13.7%
Regions Covered	Global
No. of Companies Mentioned	27

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3471EUR$3,939USD£3,022GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3745EUR$4,249USD£3,259GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5075EUR$5,759USD£4,418GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6142EUR$6,969USD£5,346GBP

Heart Failure POC & LOC Devices Market - Global Forecast 2026-2032

Market Snapshot: Heart Failure POC & LOC Devices Market Insights

Scope & Segmentation of the Heart Failure POC & LOC Devices Market

Key Takeaways for Senior Decision-Makers

Tariff Impact and Commercial Response in 2025

Methodology & Data Sources

Why This Report Matters: Actionable Insights for Your Strategy

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot: Heart Failure POC & LOC Devices Market Insights

Scope & Segmentation of the Heart Failure POC & LOC Devices Market

Key Takeaways for Senior Decision-Makers

Tariff Impact and Commercial Response in 2025

Methodology & Data Sources

Why This Report Matters: Actionable Insights for Your Strategy

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Heart Failure POC and LOC Devices - Global Strategic Business Report

Heart Failure POC And LOC Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Cardiac POC Testing Devices Market - Global Forecast 2026-2032

Cardiac PoC Testing Devices Market 2025-2033

Cardiac POC Testing Devices - Global Strategic Business Report

About the Heart Failure POC Device Market